Clinical Trial Update: A Study Comparing Pre- and Post-Change Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma [Phase 1]

View source ↗

Summary

A phase 1 clinical trial investigating pre- and post-change Teclistamab in participants with relapsed or refractory multiple myeloma is currently active but not…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Teclistamab (teclistamab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Relapsed or Refractory Multiple Myeloma | Phase 1 | Status: ACTIVE_NOT_RECRUITING